Discover how the final rule from the CDC expands access to the World Trade Center (WTC) Health Program, now including Pentagon and Shanksville responders. This course unpacks the statutory changes, capped at 500 new enrollees, detailing the impact and compliance with...
Telemedicine Flexibilities: Extending Prescription Access
$19.99
Stay ahead with the latest in telemedicine regulation. Learn how the DEA’s third extension of prescription flexibilities impacts your practice. Ensure compliance and understand the legal framework for prescribing controlled medications through telemedicine until December 31, 2025. Equip yourself with the knowledge to effectively maintain patient care in the evolving landscape of healthcare delivery.
In this course you will learn the following:
* Understand the scope and purpose of the third temporary extension of telemedicine flexibilities.
* Identify the key requirements and conditions under which controlled medications can be prescribed via telemedicine.
* Recognize the legal and regulatory framework supporting this temporary rule.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Additional information
| Federal Register Title | Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. Document Number: 2024-27018 |
|---|---|
| Course SKU | FR-24-179-1 |
| Why This Course Is Important | Healthcare providers not taking this course may miss out on critical updates affecting their ability to legally prescribe controlled medications via telemedicine. This could lead to compliance issues and potential legal repercussions. |